Medication Reconciliation Process in Clinical Practice

NCT ID: NCT07001137

Last Updated: 2025-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

386 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-15

Study Completion Date

2022-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looks at how reviewing and confirming a patient's medications during a hospital stay can help reduce problems after they go home. It focuses on patients aged 75 and older who were admitted to a short-stay geriatric unit. The researchers compared three groups:

* Patients who did not receive any medication reconciliation (CTM),
* Patients who received CTM only at hospital admission,
* Patients who received CTM at both admission and discharge.

The goal was to see if this process could lower the number of hospital readmissions, emergency room visits, and deaths within six months after discharge. The study is based on real data from a hospital in 2019 and was conducted by pharmacists and doctors working together.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Reconciliation Patient Safety Geriatrics Hospital Readmission Pharmaceutical Services Transitions of Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients who did not receive any medication reconciliation (CTM)

No interventions assigned to this group

Patients who received CTM only at hospital admission

No interventions assigned to this group

Patients who received CTM at both admission and discharge

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All patients admitted to the short-stay geriatric unit of Casanova Hospital Between January 1st and August 31st, 2019

Exclusion Criteria

\- Patients who were discharged and then readmitted to the short-stay unit after a brief transfer to another unit (e.g., surgery, internal medicine, or intensive care).
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier de Saint-Denis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

France

Saint-Denis, France, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0014_CASA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reducing Transition Drug Risk
NCT00370916 COMPLETED NA